The Phase 1 study of RLS-1496, the first human trial of a GPX4 (selective glutathione peroxidase 4) modulator, met its primary endpoint and also demonstrated a statistically significant relationship ...
VANCOUVER, BC / ACCESS Newswire / January 29, 2026 / LIR Life Sciences Corp. (CSE:SKNY)(OTC PINK:BBCMF)(Frankfurt:N790, WKN:A41QA9) ("LIR" or the "Company")is pleased to announce positive interim ...
Wave Life Sciences (WVE – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst on November 12. Analyst Joseph Schwartz from Leerink Partners reiterated a Buy rating ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results